Novo Nordisk A/S

Novo Nordisk A/S Common Stock

About This Listing

Global healthcare company leading in diabetes care and obesity treatment. Maker of Ozempic, Wegovy, and insulin products.

Company Financials

Annual Revenue $114,000.00M
Net Profit $86,000.00M
Company Valuation $1,322,000.00M
Market Cap $3.48M

Price History

Current Price

$36.63

Available Shares 58,924
Total Shares 95,000
Min Purchase 1
Max Purchase 5,000
38% sold 36,076 / 95,000

Related Listings